CellChorus
The dynamic single-cell analysis company
- Founded
- 2020
- Status
- Active
- Stage
- Early
- Team size
- 4
- Location
- Houston, TX, USA
- Category
- Biotech & Drug Discovery
- Sector
- Drug Discovery and Delivery
About CellChorus
At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI
Federal research funding
10 NIH awards totalling $6,573,723, FY2023 to FY2026.
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
- Functional signatures of post-infusion CAR T cells for early indication of patient response
- LF-TIMING: Large-scale label-free profiling of cell-cell interactions
- Dynamic single-cell analysis instrument to evaluate immune cell function
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
